Show source-provided references
2. Sui, L., Wang, J., Jiang, W.G., Song, X., and Ye, L. (2024). Molecular mechanism of bone metastasis in breast cancer. Front. Oncol., 13.
10.3389/fonc.2024.1401113 ↗6. Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells
10.1016/j.ccr.2010.12.022 ↗9. Unravelling the complexity of metastasis—Molecular understanding and targeted therapies
10.1038/nrc3125 ↗11. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A randomised, double-blind study
10.1016/S0140-6736(10)62344-6 ↗12. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: A randomized, double-blind study
10.1200/JCO.2010.29.7101 ↗13. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma
10.1200/JCO.2010.31.3304 ↗14. Del Conte, A., De Carlo, E., Bertoli, E., Stanzione, B., Revelant, A., Bertola, M., Spina, M., and Bearz, A. (2022). Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications. Int. J. Mol. Sci., 23.
10.3390/ijms23126832 ↗17. Pathi, S.P., Kowalczewski, C., Tadipatri, R., and Fischbach, C. (2010). A novel 3-D mineralized tumor model to study breast cancer bone metastasis. PLoS ONE, 5.
10.1371/journal.pone.0008849 ↗20. Microcalcifications in breast cancer: Novel insights into the molecular mechanism and functional consequence of mammary mineralisation
10.1038/bjc.2011.583 ↗21. Sohn, H.S., and Oh, J.K. (2019). Review of bone graft and bone substitutes with an emphasis on fracture surgeries. Biomater. Res., 23.
10.1186/s40824-019-0157-y ↗23. Fabrication and Biological Activity of 3D-Printed Polycaprolactone/Magnesium Porous Scaffolds for Critical Size Bone Defect Repair
10.1021/acsbiomaterials.9b01911 ↗24. Jeong, J., Kim, J.H., Shim, J.H., Hwang, N.S., and Heo, C.Y. (2019). Bioactive calcium phosphate materials and applications in bone regeneration. Biomater. Res., 23.
10.1186/s40824-018-0149-3 ↗26. Sprio, S., Dapporto, M., Montesi, M., Panseri, S., Lattanzi, W., Pola, E., Logroscino, G., and Tampieri, A. (2016). Novel Osteointegrative Sr-Substituted Apatitic Cements Enriched with Alginate. Materials, 9.
10.3390/ma9090763 ↗27. Montesi, M., Panseri, S., Dapporto, M., Tampieri, A., and Sprio, S. (2017). Sr-substituted bone cements direct mesenchymal stem cells, osteoblasts and osteoclasts fate. PLoS ONE, 12.
10.1371/journal.pone.0172100 ↗29. Effectiveness of UV-C radiation in inactivation of microorganisms on materials with different surface structures
30. Tapia-Guerrero, Y.S., Del Prado-Audelo, M.L., Borbolla-Jiménez, F.V., Gomez, D.M.G., García-Aguirre, I., Colín-Castro, C.A., Morales-González, J.A., Leyva-Gómez, G., and Magaña, J.J. (2020). Effect of UV and Gamma Irradiation Sterilization Processes in the Properties of Different Polymeric Nanoparticles for Biomedical Applications. Materials, 13.
10.3390/ma13051090 ↗31. Mercatali, L., Spadazzi, C., Miserocchi, G., Liverani, C., De Vita, A., Bongiovanni, A., Recine, F., Amadori, D., and Ibrahim, T. (2016). The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts. Int. J. Mol. Sci., 17.
10.3390/ijms17111827 ↗32. Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events
10.4161/cc.28401 ↗33. The potential role of the extracellular matrix in the activity of trabectedin in UPS and L-sarcoma: Evidences from a patient-derived primary culture case series in tridimensional and zebrafish models
10.1186/s13046-021-01963-1 ↗34. Guerrieri, A.N., Bellotti, C., Penzo, M., Columbaro, M., Pannella, M., De Vita, A., Gambarotti, M., Mercatali, L., Laranga, R., and Dozza, B. (2023). A novel patient-derived immortalised cell line of myxofibrosarcoma: A tool for preclinical drugs testing and the generation of near-patient models. BMC Cancer, 23.
10.1186/s12885-023-11658-9 ↗35. Rapid and simple comparison of messenger RNA levels using real-time PCR
10.1251/bpo114 ↗36. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development
10.1172/JCI3523 ↗38. Engineering a Novel 3D Printed Vascularized Tissue Model for Investigating Breast Cancer Metastasis to Bone
10.1002/adhm.201900924 ↗39. Human breast cancer bone metastasis In Vitro and In Vivo: A novel 3D model system for studies of tumour cell-bone cell interactions
10.1007/s10585-015-9737-y ↗44. Glaser, D.E., Curtis, M.B., Sariano, P.A., Rollins, Z.A., Shergill, B.S., Anand, A., Deely, A.M., Shirure, V.S., Anderson, L., and Lowen, J.M. (2022). Organ-on-a-chip model of vascularized human bone marrow niches. Biomaterials, 280.
10.1016/j.biomaterials.2021.121245 ↗45. Potentiation of the antitumor effect of calcium phosphate cement containing anticancer drug and caffeine on rat osteosarcoma
10.1007/s00776-011-0045-3 ↗49. Bi-directional modulation of cellular interactions in an In Vitro co-culture model of tendon-to-bone interface
10.1111/cpr.12493 ↗50. Dapporto, M., Tavoni, M., Restivo, E., Carella, F., Bruni, G., Mercatali, L., Visai, L., Tampieri, A., Iafisco, M., and Sprio, S. (2022). Strontium-doped apatitic bone cements with tunable antibacterial and antibiofilm ability. Front. Bioeng. Biotechnol., 10.
10.3389/fbioe.2022.969641 ↗51. Sheng, X., Li, C., Wang, Z., Xu, Y., Sun, Y., Zhang, W., Liu, H., and Wang, J. (2023). Advanced applications of strontium-containing biomaterials in bone tissue engineering. Mater. Today Bio, 20.
10.1016/j.mtbio.2023.100636 ↗52. Liverani, C., De Vita, A., Minardi, S., Kang, Y., Mercatali, L., Amadori, D., Bongiovanni, A., La Manna, F., Ibrahim, T., and Tasciotti, E. (2019). A biomimetic 3D model of hypoxia-driven cancer progression. Sci. Rep., 9.
10.1038/s41598-019-48701-4 ↗53. Bone-matrix mineralization dampens integrin-mediated mechanosignalling and metastatic progression in breast cancer
10.1038/s41551-023-01077-3 ↗54. Pylostomou, A., Demir, Ö., and Loca, D. (2023). Calcium phosphate bone cements as local drug delivery systems for bone cancer treatment. Biomater. Adv., 148.
10.1016/j.bioadv.2023.213367 ↗55. Dewhurst, R.M., Scalzone, A., Buckley, J., Mattu, C., Rankin, K.S., Gentile, P., and Ferreira, A.M. (2020). Development of Natural-Based Bone Cement for a Controlled Doxorubicin-Drug Release. Front. Bioeng. Biotechnol., 8.
10.3389/fbioe.2020.00754 ↗56. Modulation of Alendronate release from a calcium phosphate bone cement: An In Vitro osteoblast-osteoclast co-culture study
10.1016/j.ijpharm.2018.11.023 ↗58. Bassi, G., Panseri, S., Dozio, S.M., Sandri, M., Campodoni, E., Dapporto, M., Sprio, S., Tampieri, A., and Montesi, M. (2020). Scaffold-based 3D cellular models mimicking the heterogeneity of osteosarcoma stem cell niche. Sci. Rep., 10.
10.1038/s41598-020-79448-y ↗59. In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture
10.1073/pnas.84.14.5029 ↗60. The effect of the histoculture drug response assay (HDRA) based perioperative chemotherapy for non-small cell lung cancer
61. Therapeutic response to CDK4/6 inhibition in breast cancer defined by Ex Vivo analyses of human tumors
10.4161/cc.21195 ↗